| Literature DB >> 27375694 |
Saroona Haroon1, Muhammad Usman Tariq2, Aisha Memon3, Saira Fatima4, Sheema Habibul Hasan5.
Abstract
OBJECTIVES: To present the clinicopathological experience of Olfactory Neuroblastoma (ONB) with emphasis on histopathological and immunohistochemical features.Entities:
Keywords: Esthesioneuroblastoma; Immunohistochemistry; Olfactoryneuroblastoma; Sinonasal tract
Year: 2016 PMID: 27375694 PMCID: PMC4928403 DOI: 10.12669/pjms.323.9738
Source DB: PubMed Journal: Pak J Med Sci ISSN: 1681-715X Impact factor: 1.088
Summary of clinicopathological features of Olfactory neuroblastoma. (n=36).
| Male | 21 (58.8%) |
| Female | 17 (47.2%) |
| Symptoms | |
| Nasal obstruction | 17 (47.2%) |
| Epistaxis | 05 (13.8%) |
| Proptosis | 02 (5.6%) |
| Headache & vomiting | 01 (2.8%) |
| Not specified | 16 |
| Nasal cavity | 28 (77.8%) |
| Maxillary sinus | 07 (19.4%) |
| Sphenoid sinus | 06 (16.6%) |
| Ethmoid sinus | 05 (13.8%) |
| Frontal sinus | 03 (8.4%) |
| Infrotemporal fossa | 02 (5.6%) |
| Frontal lobe of brain | 01 (2.8%) |
| Stage A | 21 (58.3%) |
| Stage B | 13 (36.1%) |
| Stage C | 01 (2.8%) |
Histological features of Olfactoryneuroblastoma. (n=36).
| Grade 1 | 13 (36.1%) |
| Grade 2 | 08 (22.2%) |
| Grade 3 | 11 (30.6%) |
| Grade 4 | 04 (11.1%) |
| Lobules only | 16 (44.4%) |
| Sheets only | 05 (13.9%) |
| Lobules & sheets | 10 (27.8%) |
| Lobules & trabeculae | 01 (2.8%) |
| Lobules, sheets & Trabeculae | 03 (8.3%) |
| Reticular | 01 (2.8%) |
| Neurofibrillary matrix | 24 (66.7%) |
| Rosettes | 14 (38.9%) |
| Necrosis | 07(19.4%) |
| Calcification | 03 (8.3%) |
| Glands | 02 (5.6%) |
Fig. 1Grade 1 olfactory neuroblastoma arranged in lobules with abundant neurofibrillary matrix and a rim of flattened sustentacular cells at the periphery of lobules. (H&E stain 200x magnification) Grade 4 olfactory neuroblastoma arranged in pattern-less sheets of markedly pleomorphic tumor cells. (H&E stain 200x magnification) Tumor cells invading into the brain tissue. (H&E stain 200x magnification)
Expression of immunohistochemical stains performed.
| Neuron Specific Enolase | 22 | 18 (81.8%) |
| Neurofilament | 17 | 10 (58.8%) |
| Synaptophysin | 17 | 10 (58.8%) |
| Chromogranin A | 21 | 14 (66.6%) |
| CD56 | 13 | 10 (77%) |
| Cytokeratin AE1/AE3 | 24 | 07 (33.3%) |
| Cytokeratin CAM 5.2 | 24 | 02 (8.3%) |
| Vimentin | 09 | 05 (55.5%) |
| S100 | 16 | 09 (56.2%) |
| GFAP | 07 | 02 (28.5%) |
| CD99 (MIC-2) | 11 | 00 |
| Lymphoid markers | 16 | 00 |
| Desmin | 10 | 00 |
| MyoD1 | 03 | 00 |
| HMB45 | 01 | 00 |
| TTF-1 | 01 | 00 |
| Calretinin | 01 | 00 |
Fig.2Tumor cells demonstrating diffuse and strong cytoplasmic positivity for Neuron Specific Enolase (NSE) immunohistochemical stain. Tumor cells demonstrating diffuse and strong cytoplasmic positivity for Chromogranin A. S100 immunohistochemical stain highlighting sustentacular cells at the periphery of lobules. Tumor cells demonstrating focal positivity for Cytokeratin AE1/AE3 immunohistochemical stain.